RxDoctor Payments DataLook up a doctor →

Young Il Seo, MD

Physical Medicine & Rehabilitation · Liverpool, NYNPI 1235559527

Payments from drug & device makers

$9,414in general payments, 2019–2025

Across 434 payments — averaging $21.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Nevro Corp.$1K
  • Abbott$782
  • Collegium Pharmaceutical, Inc.$701
  • Medtronic$628
  • Pfizer$407
  • plus $4K from 39 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)109$2,106
Nevro Corp.12$1,158
Abbott25$782
Collegium Pharmaceutical, Inc.47$701
Medtronic16$628
Pfizer31$407
Merz Pharmaceuticals, LLC12$300
Biohaven Pharmaceutical Holding Company Ltd.25$291
Averitas Pharma Inc.13$262
Lilly USA, LLC15$251
Boston Scientific8$242
Vertos Medical, Inc.5$223
Si-bone, Inc.3$192
Amgen(2 entities)12$179
Biodelivery Sciences International, Inc.14$163
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC13$155
Teva Pharmaceuticals USA, Inc.7$105
Lundbeck LLC4$94
Biohaven Pharmaceuticals, Inc.5$90
Globus Medical2$82
SPR Therapeutics, Inc6$82
MDD US Operations, LLC4$73
Arbor Pharmaceuticals, Inc.5$72
Vertex3$64
Saluda Medical Americas, Inc.3$63
Prodigy Surgical Distribution, Inc.1$56
Scilex Pharmaceuticals Inc.3$53
Foundation Fusion Solutions, LLC1$53
Kowa Pharmaceuticals America, Inc.3$52
IBSA Pharma Inc.3$49
Almatica Pharma LLC3$49
Pacira Therapeutics, Inc.2$40
Fidia Pharma USA Inc.2$34
Merz North America, Inc.2$34
Redhill Biopharma Inc.2$31
Amneal Pharmaceuticals LLC2$30
Assertio Therapeutics, Inc.2$30
Bioventus LLC2$28
Tonix Medicines, Inc.1$23
Vertical Pharmaceuticals, LLC1$17
Sentynl Therapeutics, Inc.1$15
International Rehabilitative Sciences, Inc1$15
AstraZeneca1$15
Metacel Pharmaceuticals LLC1$14
GRT US Holding, Inc.1$11

How this compares

$9,414 in reported general payments places this provider in the 90th percentile of 872 physical medicine & rehabilitation providers in New York.

See all physical medicine & rehabilitation providers in New York →

Medicare billing

Part B allowed, 2024
$191,748
Medicare patients
441
Services billed
11,512

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physical medicine & rehabilitation in Liverpool

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →